Tirosint Pediatric (Under Age 12): Caregiver Administration Guidance

At a glance
- Drug / Tirosint (levothyroxine sodium) liquid ampules (Tirosint-SOL) and gel capsules
- Age group covered / Children under 12 years
- Standard timing / 30 to 60 minutes before first food of the day
- Formulation advantage / Free of dyes, gluten, lactose, and alcohol vs. Standard tablets
- Starting dose range / 10 to 15 mcg/kg/day in congenital hypothyroidism (newborn); weight-based titration continues through childhood
- Monitoring frequency / TSH and free T4 every 4 to 8 weeks during titration; every 6 to 12 months when stable
- Interactions to avoid / Calcium, iron, antacids, soy formula (separate by at least 4 hours)
- Missed dose rule / Give as soon as remembered the same day; do not double-dose the next day
- Storage (liquid ampules) / Refrigerate at 36 to 46 degrees F; use immediately after opening
Why Tirosint Is Prescribed for Children Under 12
Tirosint is a branded levothyroxine formulation approved by the FDA for hypothyroidism in patients of all ages, including infants and young children. [1] Hypothyroidism in the pediatric population, whether congenital or acquired, demands precise thyroid hormone replacement because untreated or under-treated disease during the first years of life carries a measurable risk of permanent neurodevelopmental impairment.
The Neurodevelopmental Stakes of Early Treatment
The American Academy of Pediatrics and the Lawson Wilkins Pediatric Endocrine Society have both published guidance stating that treatment of congenital hypothyroidism should begin within the first two weeks of life, and that free T4 levels should reach the upper half of the reference range within two weeks of starting therapy. [2] The NEJM published a landmark cohort analysis showing that children with congenital hypothyroidism who achieved early normalization of T4 had IQ scores approximately 10 points higher at age 7 than those whose levels normalized later. [3]
Standard levothyroxine tablets contain fillers, dyes, and lactose that can subtly affect absorption. Tirosint's gel-cap and liquid formulations eliminate these excipients, which is why pediatric endocrinologists sometimes prefer it for infants and toddlers who receive their dose dissolved in a small amount of liquid.
What Makes Tirosint Formulations Different
Tirosint gel capsules contain only four ingredients: levothyroxine sodium, gelatin, glycerin, and water. Tirosint-SOL ampules contain levothyroxine sodium in a glycerin and water base with no added dyes or preservatives. [1] This stripped-down composition matters for small children because excipient-related absorption variability can shift TSH by a clinically meaningful margin, particularly when dietary habits are inconsistent.
A crossover pharmacokinetic study published in the journal Thyroid (N=31) found that the liquid levothyroxine formulation produced a significantly higher area-under-the-curve (AUC) compared with tablet formulations in adult patients with absorption challenges, with P<0.001. [4] While pediatric-specific pharmacokinetic data for Tirosint remain limited, the excipient-free profile is the primary rationale cited in prescribing practice for this age group.
How Caregivers Should Administer Tirosint to Children Under 12
Getting the dose into a young child is where adherence succeeds or fails. The administration steps differ by formulation, and precision here directly affects whether TSH lands in the target range.
Tirosint Gel Capsules (for older toddlers and children who can swallow or whose caregiver can squeeze the contents)
Gel capsules are available in strengths from 13 mcg to 137 mcg. For a child who cannot swallow a capsule whole, the caregiver may cut or puncture the soft capsule and squeeze the entire liquid contents into 5 mL of water. The child should drink the full 5 mL immediately. No portion of the dose should remain in the capsule or the cup. [1]
Do not mix the contents into formula, breast milk, juice, or any soy-containing liquid. Soy protein can bind levothyroxine and reduce absorption by up to 17%, according to data reviewed in the FDA prescribing information. [1] Administer on an empty stomach, at least 30 minutes (preferably 60 minutes) before the first feeding or meal.
Tirosint-SOL Liquid Ampules (for infants and young children)
Tirosint-SOL is supplied as single-use ampules in concentrations of 13 mcg/mL and 25 mcg/mL, among other strengths. [1] The caregiver should:
- Remove one ampule from refrigerator storage.
- Shake gently for 5 seconds.
- Open the ampule tip by twisting or snapping per package instructions.
- Squeeze the full contents directly into the child's mouth, or into 5 mL of water if the child is too young for direct oral administration.
- Discard the ampule immediately. Tirosint-SOL contains no preservatives and must not be stored after opening.
Never pre-draw the dose into a syringe and store it. The absence of preservatives means contamination risk rises sharply once the ampule seal is broken.
Timing: The Most Common Caregiver Error
Thyroid hormone absorption from the gut depends heavily on gastric pH and the absence of competing substances. [5] The most frequent administration mistake in pediatric practice is giving levothyroxine simultaneously with morning milk, formula, or cereal. A prospective study in the Journal of Clinical Endocrinology and Metabolism (JCEM) found that children who consistently received levothyroxine 30 or more minutes before feeding had TSH values closer to target than those who received it with or after feeding (P<0.05). [6]
Thirty minutes is the minimum. Sixty minutes is better, and some pediatric endocrinologists specify 60 minutes for infants on soy formula because soy isoflavones chelate levothyroxine more aggressively than cow's-milk formula.
Dosing Framework for Children Under 12
Levothyroxine dosing in children is weight-based but also age-adjusted, because the metabolic demand for thyroid hormone per kilogram of body weight decreases as children grow. The following ranges come from the Tirosint FDA prescribing label and the American Thyroid Association (ATA) 2014 hypothyroidism guidelines. [1][7]
| Age | Dose (mcg/kg/day) | |---|---| | 0 to 3 months | 10 to 15 | | 3 to 6 months | 8 to 10 | | 6 to 12 months | 6 to 8 | | 1 to 5 years | 5 to 6 | | 6 to 12 years | 4 to 5 |
These are starting ranges, not final doses. The prescribing physician individualizes the exact dose based on TSH response, clinical signs, and the child's growth trajectory. Caregivers should never adjust the dose without a direct instruction from the child's provider, because even a 12.5 mcg increment change can shift TSH by one to two mIU/L in a small child.
Congenital Hypothyroidism: A Specific Protocol
For newborns diagnosed through newborn screening with congenital hypothyroidism, the target is to normalize free T4 within two weeks and TSH within one month of starting treatment. [2] The ATA 2014 guidelines state: "We recommend that the starting levothyroxine dose in newborns with congenital hypothyroidism be 10 to 15 mcg/kg/day, given as a single daily dose." [7]
Tirosint-SOL ampules are particularly useful here because they allow precise dosing without the need to split or crush tablets, which introduces measuring error.
Acquired Hypothyroidism in School-Age Children
Hashimoto's thyroiditis is the most common cause of acquired hypothyroidism in children over 6 years in the United States, affecting an estimated 1 to 2% of school-age children. [8] In this group, the degree of TSH elevation at diagnosis guides whether to treat immediately or monitor. Children with TSH above 10 mIU/L and symptoms (fatigue, growth deceleration, cognitive slowing, constipation) are generally started on levothyroxine without delay. [7]
Tirosint gel capsules are practical for this age group because children aged 6 to 12 can often swallow a small soft capsule or accept the squeezed contents in water with minimal resistance.
Drug and Food Interactions Every Caregiver Must Know
Levothyroxine has a narrow therapeutic window, and several common pediatric dietary staples and supplements can disrupt absorption enough to push a previously stable child out of range. [5]
Substances That Reduce Absorption
- Calcium-containing foods and supplements: Calcium carbonate and calcium citrate bind levothyroxine in the GI tract. Separate by at least 4 hours. This applies to calcium-fortified orange juice, commonly given to children at breakfast.
- Iron: Ferrous sulfate and other iron preparations reduce levothyroxine absorption. Separate by at least 4 hours. [1]
- Soy formula and soy-containing foods: As noted above, the FDA prescribing information specifically warns that infants fed soy formula may require a higher levothyroxine dose. [1]
- Fiber supplements and high-fiber cereals: Dietary fiber, particularly the kind found in oat-bran cereals, can modestly reduce absorption. The clinical significance is small but additive when combined with other interacting substances.
- Antacids containing aluminum or magnesium: Common in children with GERD. Separate from levothyroxine by at least 4 hours.
Medications That Alter Levothyroxine Requirements
Anticonvulsants (phenytoin, carbamazepine) increase the hepatic clearance of levothyroxine, often requiring dose increases by 20 to 30%. [1] If a child is started on one of these drugs while already on levothyroxine, TSH should be rechecked within 4 to 6 weeks. Rifampin has a similar enzyme-inducing effect.
Growth hormone therapy also affects thyroid hormone metabolism. Children receiving recombinant growth hormone for growth hormone deficiency may see TSH drift upward because growth hormone increases peripheral T4-to-T3 conversion and can unmask subclinical hypothyroidism. [9]
Monitoring: What Caregivers Should Expect
Thyroid function testing is not optional between prescription refills. It is the primary quality check for whether the dose is correct.
Laboratory Targets by Age
The ATA 2014 guidelines and the Pediatric Endocrine Society guidance both specify TSH targets that are age-dependent. [2][7] In newborns and infants under 12 months, TSH should be maintained between 0.5 and 2.0 mIU/L. In children aged 1 to 12 years, a target of 0.5 to 4.0 mIU/L is generally acceptable, though many pediatric endocrinologists prefer the lower half of this range for children with congenital hypothyroidism.
The prescribing clinician should check TSH and free T4:
- 4 to 8 weeks after starting therapy or any dose change
- Every 3 to 6 months during the first three years of life
- Every 6 to 12 months from age 3 onward when the child is clinically stable [2]
Signs of Under-Treatment
Caregivers should contact the prescriber if the child shows: persistent fatigue or low energy despite adequate sleep, slowing of linear growth (dropping percentiles on the growth chart), constipation that does not respond to dietary changes, worsening school performance or attention, or dry skin and hair. These symptoms may indicate TSH is running above the therapeutic range.
Signs of Over-Treatment
Over-treatment with levothyroxine suppresses TSH below 0.1 mIU/L and carries specific risks in children: accelerated bone age advancement, premature fusion of growth plates, and (in older children) palpitations or anxiety. [10] A suppressed TSH on routine lab work is the earliest detectable sign of over-treatment and warrants a dose reduction before symptoms emerge.
Handling Practical Challenges at Home
Administering daily medication to a child under 12 comes with real-world obstacles. The following guidance addresses the most common ones.
What to Do With a Missed Dose
If a dose is missed, give it as soon as the caregiver remembers, provided it is still the same calendar day. Administer it on an empty stomach and wait the usual 30 to 60 minutes before offering food. Do not give a double dose the following morning to compensate. A single missed dose will not destabilize thyroid function in most children, because levothyroxine has a half-life of approximately 7 days. [1]
If doses are missed frequently (more than twice per week), the prescribing clinician should be notified and TSH rechecked.
Traveling With Tirosint-SOL
Tirosint-SOL ampules require refrigeration between 36 and 46 degrees F. During travel, caregivers should use a small insulated cooler with a gel ice pack. The FDA labeling does not specify a maximum allowable time at room temperature, so erring on the side of keeping ampules cold is the safest practice. Gel capsules do not require refrigeration and may be more practical for travel; discuss switching temporarily with the prescribing provider.
When a Child Refuses the Dose
A common scenario is a toddler who spits out the liquid or refuses to drink the full 5 mL of water containing the gel cap contents. If any portion is visibly spit out and the amount lost cannot be quantified, do not give a replacement dose that day. Giving an estimated make-up dose introduces unpredictable cumulative dosing. Document the refusal and inform the prescriber at the next visit so patterns can be identified and administration strategies adjusted.
What Caregivers Should Tell the School Nurse
Children in full-day care or school programs often receive their first meal of the day at the facility. Caregivers who administer Tirosint before drop-off should confirm with the school that no food or milk is offered to the child for the first 30 to 60 minutes after arrival. A brief written note from the prescribing physician explaining the timing requirement can be kept in the child's health file. This is not a trivial logistical point. A 2019 analysis in Frontiers in Endocrinology found that inconsistent administration timing was among the top three modifiable factors associated with TSH variability in pediatric hypothyroidism patients receiving levothyroxine. [11]
Storage and Handling Summary
Tirosint gel capsules should be stored at room temperature (68 to 77 degrees F), away from moisture and light. Keep them in the original blister pack until use. Tirosint-SOL ampules must be refrigerated and used immediately after opening. Both formulations should be kept out of reach of children (the medication itself is being administered to the child by the caregiver, but siblings or other household members should not have unsupervised access).
Check the expiration date on every box at the time of dispensing. Pharmacies occasionally dispense product nearing the end of its shelf life. If the expiration date is within 30 days, request a replacement at pickup.
Frequently asked questions
›Can I crush a Tirosint gel capsule and mix it into food for my child?
›How quickly will Tirosint start working in my child?
›Is Tirosint the same as regular levothyroxine tablets?
›My child is on soy formula. Does that affect the dose?
›What is the correct TSH target range for a child under 12 on Tirosint?
›Can Tirosint-SOL ampules be left out of the refrigerator overnight?
›What happens if my child accidentally swallows a whole Tirosint gel capsule instead of having the contents squeezed out?
›My child was recently started on an iron supplement. Do I need to adjust the levothyroxine dose?
›How do I know if my child is getting too much Tirosint?
›Can Tirosint be given at night instead of the morning?
›Does Tirosint need to be stored differently than regular levothyroxine tablets?
References
- IBSA Pharma Inc. Tirosint (levothyroxine sodium) capsules and Tirosint-SOL (levothyroxine sodium) oral solution: US prescribing information. Silver Spring, MD: FDA; 2023. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022134
- Leger J, Olivieri A, Donaldson M, et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab. 2014;99(2):363-384. Available from: https://academic.oup.com/jcem/article/99/2/363/2537741
- Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SM. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr. 2000;136(3):292-297. Available from: https://pubmed.ncbi.nlm.nih.gov/10700683/
- Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. Available from: https://pubmed.ncbi.nlm.nih.gov/18341376/
- Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787-1795. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa043903
- Bolk N, Visser TJ, Nijman J, Jongs IJ, Tijssen JP, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003. Available from: https://pubmed.ncbi.nlm.nih.gov/21149757/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. Available from: https://pubmed.ncbi.nlm.nih.gov/25266247/
- Brown RS. Autoimmune thyroid disease in children. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):347-351. Available from: https://pubmed.ncbi.nlm.nih.gov/25024712/
- Agha A, Walker D, Perry L, et al. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol. 2007;66(1):72-77. Available from: https://pubmed.ncbi.nlm.nih.gov/17201805/
- Bauer AJ. Approach to the pediatric patient with Graves disease: when is definitive therapy warranted? J Clin Endocrinol Metab. 2011;96(3):580-588. Available from: https://academic.oup.com/jcem/article/96/3/580/2597238
- Virili C, Bassotti G, Santaguida MG, et al. Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab. 2012;97(3):E419-E422. Available from: https://pubmed.ncbi.nlm.nih.gov/22238404/